Walking through the halls of Netflix’s (Nasdaq: NFLX) headquarters in Los Gatos, Calif., during the holidays must have been a gloomy affair. Legions of employees that receive some of their compensation in company stock saw their holdings plunge in value as the video service company saw its… Read More

It appears as if we’ve finally shaken the ghost of the dot-com bubble. The Nasdaq Index has been moving up sharply during the past few years and now trades at levels seen back in 2000, and a few recent dot-com IPOs are now… Read More

U.S. investors are always in search of “the next Google (Nasdaq: GOOG),” hoping to latch on to a stock that can appreciate smartly over many years. In China, they’ve already had their Google moment. The country’s leading search engine provider, Baidu.com (Nasdaq: BIDU) has seen its… Read More

A rising market and a still-slow economy have created a real conundrum. Should you focus on the increasingly smaller group of deep-value stocks, or should you step on the gas, searching for stocks that are set for… Read More

It has yet to happen, but some day a public company could reach a total market capitalization of a trillion dollars. Think it can’t happen? Consider that in this era of a global… Read More

The social media freshmen are entering their sophomore year. LinkedIn (Nasdaq: LNKD), Groupon (Nasdaq: GRPN) and Zynga (Nasdaq: ZNGA) have shaken off the post-IPO jitters, so now investors have the clearest picture yet of how large these companies can grow in the coming quarters and years. [block:block=16]I’ve… Read More

A key challenge in the pharmaceutical industry these days is the staggering amount of drugs losing their patent protection. Back in November 2011, Pfizer’s (NYSE: PFE) Lipitor — the company’s all-time best-selling drug, which reported annual sales in excess of $10 billion at its peak — lost its patent protection. Read More

Last summer, when Netflix (Nasdaq: NFLX) was messing with its pricing plans, alienating its customers in the process, I spotted a clear opening for rival Coinstar (Nasdaq: CSTR), which runs a kiosk-based DVD distribution system. As I wrote then: “Thanks to Netflix, Coinstar’s DVD business will thrive… Read More

I’ve noted on a few occasions that investing in shares of biotech companies is quite challenging for the average investor. In this case, as I suggested a few weeks ago, a biotech fund may be the best choice for some, since it reduces the… Read More

My loss is your gain.  Less than a month ago, I told readers about the potentially strong upturn in place for carbon fiber maker Zoltek (Nasdaq: ZOLT). Thanks to a just-released quarterly report, shares… Read More